Dr Rachel Cox, is a consultant paediatric oncologist and Chair of CCLG’s Late Effects Group. She tells us what late effects are, and how the work of the group is helping to improve the quality of life for survivors of childhood cancer.
Brad Gudger, diagnosed with leukaemia as a 19-year-old, tells us how he has used his own experiences to establish a charity and launch an app for cancer patients aged 18+.
Rachel Corbett’s daughter, Suki, was diagnosed with acute lymphoblastic leukaemia (ALL) in January 2017, aged four. Rachel writes about spending Christmas in hospital and how the experience has changed how her and her family think of it.
Dr Annmarie Jeanes, Consultant Paediatric Radiologist at Leeds Children’s Hospital, explains the different types of imaging your child may experience at the time of diagnosis, during treatment and follow-up
Sheila Cartwright, one of the first CCLG members and retired paediatric radiation oncologist, reflects on her career, and explains how LinkedIn allows her to keep up with developments in childhood cancer and reconnect with former patients.
With the COVID-19 pandemic delaying many of its plans, Teenagers and Young Adults with Cancer (TYAC), CCLG’s sister organisation, has revisited its ambitious 2020-2025 strategic plan. Ashley Ball-Gamble, CEO of TYAC and CCLG, explains more.
Naomi Shefford-Thomas, CCLG Information Executive and mum to Phoebe, who underwent almost four years of treatment for neuroblastoma, answers your questions.
Dr Bob Phillips, Senior Academic Consultant at University of York, Consultant Paediatric Oncologist at Leeds Children’s Hospital and CCLG member, writes...
Prof Louis Chesler leads the Paediatric Oncology Experimental Medicine (POEM) Centre at the Institute of Cancer Research (ICR). He tells us about some of the exciting digital innovations that have the potential to transform childhood cancer treatment.
